Analyst Ratings for Seres Therapeutics (MCRB) [Buys]
MCRB Rating Summary
MCRB Price Target Summary
- Highest: $12.00 (Jefferies)
- Lowest: $1.25 (Goldman Sachs)
- Average: $6.56
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$6.56 (+958.5%)
* Over Last 12-Mos
Rating Score: 8 / 10
Percentile Rank: 84%
Avg. $ Target:
$6.56 (+958.5%)
* Over Last 12-Mos
Rating Score: 8 / 10
Percentile Rank: 84%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 6/26/2023 | Oppenheimer » Updated 3/6/2024 |
Jeff Jones | New Coverage | Outperform (N/A) |
5.00 (9.00) |
5.46 (0.62) |
-88.64% | Details |
| 3/5/2021 | Chardan Capital Markets » Updated 3/6/2024 |
Keay Nakae | Upgrade | Buy (Neutral) |
8.00 (10.00) |
18.11 (0.62) |
-96.58% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
